(XTLB) Xtl Biopharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Xtl Biopharmaceuticals | (XTLB) share price targets
Complete technical analysis of Xtl Biopharmaceuticals (XTLB) by charts plus indicators, forecast predictions and share price targets for Xtl Biopharmaceuticals (XTLB)
Xtl Biopharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2024-05-20 View latest technical analysis
10 day averaged volume of Xtl Biopharmaceuticals is 14978
| Date | Daily Closing Price | Open | High | Low | Volume |
| 20 Mon May 2024 | 2.60 | 2.62 | 2.72 | 2.43 | 0.767 times |
| 17 Fri May 2024 | 2.69 | 2.80 | 2.84 | 2.69 | 0.373 times |
| 16 Thu May 2024 | 2.65 | 2.68 | 2.75 | 2.60 | 0.411 times |
| 15 Wed May 2024 | 2.74 | 2.75 | 2.79 | 2.64 | 1.178 times |
| 14 Tue May 2024 | 2.57 | 2.90 | 2.92 | 2.57 | 1.629 times |
| 13 Mon May 2024 | 2.92 | 2.74 | 2.99 | 2.73 | 3.305 times |
| 10 Fri May 2024 | 2.56 | 2.66 | 2.66 | 2.42 | 0.588 times |
| 09 Thu May 2024 | 2.40 | 2.41 | 2.45 | 2.40 | 0.207 times |
| 08 Wed May 2024 | 2.45 | 2.40 | 2.50 | 2.36 | 1.042 times |
| 07 Tue May 2024 | 2.55 | 2.45 | 2.55 | 2.26 | 0.467 times |
My analysis of stock is bullish for shortterm, and stock might move up till 2.7 or till 2.8. Use a stoploss of 2.57 and if this stock hits its stoploss, then it can fall down till 2.45
Share price targets for Xtl Biopharmaceuticals (XTLB)
| Target Type | Value |
| Downside Target | 0.77 |
| Downside Target | 0.82 |
| Downside Target | 0.85 |
| Downside Target | 0.95 |
| Downside Target | 1.17 |
| Downside Target | 2.26 |
| Downside Target | 2.35 |
| Downside Target | 2.42 |
| Downside Target | 2.57 |
| Upside Target | 2.72 |
| Upside Target | 2.73 |
| Upside Target | 2.99 |
| Upside Target | 3.48 |
| Upside Target | 4.99 |
Intraday share price targets for Xtl Biopharmaceuticals (XTLB)
| Target Type | Value |
| Downside Intraday Target | 2.45 |
| Downside Intraday Target | 2.29 |
| Upside Intraday Target | 2.74 |
| Upside Intraday Target | 2.87 |
| Downside Intraday Target | 2.58 |
Weekly technical analysis of Xtl Biopharmaceuticals (XTLB)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 20 Mon May 2024 | 2.60 | 2.62 | 2.72 | 2.43 | 0.111 times |
| 17 Fri May 2024 | 2.69 | 2.74 | 2.99 | 2.57 | 2.221 times |
| 10 Fri May 2024 | 2.56 | 2.53 | 2.66 | 2.26 | 1.243 times |
| 03 Fri May 2024 | 2.53 | 2.51 | 2.62 | 2.42 | 0.469 times |
| 26 Fri Apr 2024 | 2.42 | 2.35 | 2.73 | 2.35 | 0.486 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Xtl Biopharmaceuticals (XTLB)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 20 Mon May 2024 | 2.60 | 2.53 | 2.99 | 2.26 | 0.084 times |
| 30 Tue Apr 2024 | 2.59 | 2.75 | 3.48 | 2.35 | 0.046 times |
| 28 Thu Mar 2024 | 2.81 | 0.90 | 4.99 | 0.85 | 1145.546 times |
| 29 Thu Feb 2024 | 0.87 | 0.88 | 0.95 | 0.77 | 0.378 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Xtl Biopharmaceuticals (XTLB)
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Xtl Biopharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Xtl Biopharmaceuticals in short term but the sell signal is initial and weak.
Xtl Biopharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Xtl Biopharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Xtl Biopharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.7 and Xtl Biopharmaceuticals (XTLB) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Xtl Biopharmaceuticals (XTLB) stock. Volume based technical analysis of Xtl Biopharmaceuticals (XTLB) stock is negative.
Xtl Biopharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Xtl Biopharmaceuticals ( (XTLB) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Xtl Biopharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Xtl Biopharmaceuticals in short term but the sell signal is initial and weak.
Xtl Biopharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Xtl Biopharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Xtl Biopharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.7 and Xtl Biopharmaceuticals (XTLB) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Xtl Biopharmaceuticals (XTLB) stock. Volume based technical analysis of Xtl Biopharmaceuticals (XTLB) stock is negative.
Xtl Biopharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.